.svg){kind=small}
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Shore Natural Rx is stocked at 10 licensed dispensaries across Maryland, with the deepest coverage in Annapolis, Baltimore, Elkton, Glen Burnie, and Hagerstown. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Shore Natural Rx operated as a single-category brand with Flower accounting for 100.0% of sales and posting a month-over-month increase of 9.24% alongside a year-over-year decline of 65.08%. Average price rose 23.82% year over year to $43.78 while unit volume consequently contracted, and the brand held rank 45 in Flower in Maryland. The pattern implies a consolidation strategy around Flower that is lifting short-term velocity (up 9.24% MoM) but compressing the annual run rate (down 65.08% YoY) as higher pricing coincides with reduced breadth and lower unit throughput.
The pivot to a 100% Flower mix paired with a 23.82% YoY price increase concentrates Shore Natural Rx in a price-sensitive segment where a rank of 45 signals limited shelf advantage relative to peers, even with a 9.24% MoM uptick. With brand sales down 65.08% YoY against a 72.41% decline over 24 months, the recent month’s improvement is not yet reversing the longer slide; this positioning implies the need to convert the near-term price-led lift into sustained share gains in Maryland Flower or reintroduce mix breadth to stabilize rank and unit momentum.
Competitive Landscape
Shore Natural Rx sits at rank #45 in October 2026, sliding 8 positions from #37 year over year and inching up 3 spots from #48 over the last three months; against the category’s leaders, SunMed held #1 while posting a -4.0% year-over-year sales change and Fade Co. climbed from #3 to #2 with 39.3% growth, indicating relative share is concentrating upward as Shore Natural Rx remains 18 ranks below its March 2025 peak of #27. With RYTHM at #3 and up 8.5% YoY versus Shore Natural Rx’s 8-rank YoY decline, and District Cannabis steady at #4 alongside 14.1% YoY growth, the directional gap implies that Shore Natural Rx’s current trajectory is one of gradual mid-pack erosion that will require either mix shifts or velocity gains to re-approach its prior peak.
Notable Products
Shore Natural Rx’s sales in October 2026 were highly concentrated, with Rozay (3.5g) accounting for 49.6% and the top two items combining for 76.4%. That concentration means most of its sales ride on Rozay (3.5g) and Ghost OG (14g).
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
